GANX
- Gain Therapeutics, Inc.
()
Overview
Company Summary
Gain Therapeutics, Inc. (GANX) is a biotechnology company that focuses on the discovery and development of therapeutics that target protein misfolding diseases.
Protein misfolding diseases are a group of rare genetic disorders characterized by the improper folding and accumulation of specific proteins in the body's cells. This misfolding can lead to the dysfunction and eventual death of cells, contributing to various diseases such as lysosomal storage disorders, neurodegenerative disorders, and certain types of cancers.
Gain Therapeutics utilizes a proprietary computational drug discovery platform called SEE-Tx (Structural Ensemble Evoluti